Sometimes it is easy to overlook the importance of human resources and compliance issues.  In fact, human resource departments face significant enforcement and compliance risks.  In addition, the head of human resources is an important partner on compliance.  If a company suffers from weak compliance programs, its human resource department is sure to be a liability for the company. The Human Resources Chief has significant...

The 2012 settlements with Pfizer, Data Systems and Solutions and NORDAM all underscore an important point – when a company discovers potential violations, the company should consider implementing appropriate remediation while completing its internal investigation in order to improve its compliance program.  The Justice Department has cited this factor in determining the “discount” for cooperation and acceptance of responsibility.  In past years, early remediation has...

The Supreme Court’s decision upholding most of the Affordable Care Act increased compliance responsibilities for healthcare companies.  The ACA amended the False Claims Act (FCA), which was amended in 2009 in the Fraud Enforcement and Recovery Act. The FCA amendments in 2009 and 2010 have had a dramatic impact on businesses.  The 2009 amendments expanded the definition of “claim” and the definition of “obligation” to...

Mexico is an important trading partner with the United States.  It attracts a lot of foreign investment by United States companies.  Corruption risks are substantial and getting worse.  Mexico is ranked 100 out of 182 countries by the Transparency International’s Corruption Perceptions Index.  It has been moving down the list in the last five years. FCPA prosecutors have focused on Mexico operations.  In the last...

Pharmaceutical and medical device companies are fast becoming the enforcement punching bag, eclipsing the long-suffering status of the oil and gas energy.  If you ignore the political and public relations challenges facing the pharmaceutical and medical device industries, you are being naive.  In almost every possible area for enforcement, pharmaceutical and medical companies have been the targets of aggressive criminal, civil and regulatory action. While...

The ultimate outcome of an internal investigation is, in many respects, dictated by the investigation report.  But not all reports are created equal.  Every report reflects the specific external and internal circumstances facing a company. On the external front, the key issues are whether the government has initiated a civil and/or criminal investigation(s)?  Is there a potential whistleblower action?  Is there pending related civil litigation?...

The FCPA Paparazzi is a glitter.  Client alerts are being drafted as we speak.  Webinars and conferences will highlight this latest development – the release of the Justice Department’s FCPA “Guidance.” Not to burst any marketing plans or any promotional bubbles but I think it is pretty clear what the FCPA Guidance will contain.  The Justice Department already has given us some clues, and I...

The creation of the Consumer Financial Protection Bureau (CFPB) in the Dodd-Frank Act was a hotly contested issue.  In the end, Democrats were able to push through the creation of this new agency.  Even with some of the limitations designed to curtail the CFPB’s authorities, the CFPB is fast becoming a new and important player in the consumer finances market. The CFPB is a powerful...

I had the pleasure of recording a video with LEVICK on Whistleblowers.  LEVICK is a leading communications firm which provides strategic consulting to companies.  Please click HERE to watch the video.  LEVICK safeguards brands and reputations worldwide. The firm has been honored with multiple awards for its work ensuring public trust when it matters most, including top honors in crisis, litigation, public affairs, and investor relations,...

Unlike anti-corruption compliance, companies have long had antitrust compliance programs.  It has long been recognized that collusion between and among companies on prices, territories, and other market factors has a negative impact on consumers.  A price-fixing conspiracy which results in a modest price increase in popular products can quickly add up to billions of dollars in damages, far outpacing some of the largest fraud schemes...